Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study — KPUB

Peptic Ulcer Bleeding Clinical Trial

Official title:
Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study

Status Completed

Clinical Trial Summary

The purpose of the investigators study is to investigate the factors associated with rebleeding in patients with peptic ulcer bleeding.

Clinical Trial Description

The investigators are performing a nationwide population based cohort study to investigate the factors associated with rebleeding in patients with peptic ulcer bleeding. The results of the investigators study should give us information about patients who are at high risk of rebleeindg and enable us to manage these patients appropriately. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02152904
Study type	Observational [Patient Registry]
Source	Incheon St.Mary's Hospital
Contact
Status	Completed
Phase	N/A
Start date	April 2014
Completion date	March 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03469167` - Study to Evaluate Efficacy and Safety of Wound Dressing Solution Containing EGF in Patients With Peptic Ulcers Bleeding	N/A
Recruiting	`NCT02434978` - Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding	N/A
Completed	`NCT01822600` - The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia	Phase 4
Completed	`NCT01591486` - Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding	N/A
Withdrawn	`NCT04407832` - Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy	N/A
Completed	`NCT01591083` - The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers	Phase 4